In a dramatic move set to reshape the pharmaceutical landscape, the administration has introduced a series of tariffs aimed specifically at imported drugs. This policy shift will affect a broad range of prescription medications, from common generics to specialized treatments. Industry experts warn that patients could face significant increases in out-of-pocket costs as manufacturers and pharmacies adjust prices to accommodate the new tariffs. Some of the most impacted categories include cholesterol-lowering drugs, insulin, and cancer therapies.

Consumers and healthcare providers are bracing for potential changes in drug availability and affordability. To better understand the financial impact, here’s a brief overview of the estimated cost increase on key drug categories:

Drug Category Average Current Price Estimated Price Increase New Estimated Price
Cholesterol Medication $45 15% $52
Insulin $120 20% $144
Cancer…